SÊMEIA is a French startup that focuses on using digital technology to support healthcare professionals in providing personalized care to patients with serious or chronic illnesses. The company applies the latest AI technologies such as deep learning and sequence mining to enhance the patient experience. By leveraging predictive models based on health insurance data, Sêmeia's solutions identify at-risk patients and critical periods, enabling efficient and tailored interventions. The startup's tools interact with patients and healthcare professionals at the right moment through various channels, including digital, SMS, nurse calls, and pharmaceutical interviews.
Founded in 2017, SÊMEIA caters to clients in the health care industry, including pharmaceutical companies, scientific societies, and health insurance providers. In December 16, 2022, the company secured a significant €7.00M Venture Round investment from Orange Ventures MEA, Banque des Territoires, Malakoff Humanis. This investment is expected to further propel SÊMEIA's innovative digital healthcare solutions and expand its impact on patient care.
No recent news or press coverage available for SÊMEIA.